How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Agriculture · Forecast 2027–2033
Animal Feed Phytases Market
- By Source Type: Fungal Phytases, Bacterial Phytases, Plant-derived Phytases
- By Form: Liquid, Powder, Granular
- By Animal Type: Swine, Poultry, Ruminants, Aquaculture
- By Application: Feed Additive, Premix, Compound Feed
- By Production Method: Recombinant DNA Technology, Natural Extraction
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Fungal Phytases leads By Source Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.170 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Animal Feed Phytases Market report
A complete, evidence-based study - 12 chapters and 118 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Source Type 3
Form 3
Animal Type 4
Application 3
Production Method 2
Companies profiled
BASF SE
DuPont (IFF)
Novozymes A/S
DSM Nutritional Products
AB Enzymes GmbH
Kemin Industries Inc.
Adisseo
Chr. Hansen Holding A/S
Lallemand Inc.
Advanced Enzyme Technologies Ltd.
Jinan Bestzyme Bio-Engineering Co. Ltd.
Shandong Longlive Bio-technology Co. Ltd.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →DuPont (IFF)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Novozymes A/S
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →DSM Nutritional Products
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →AB Enzymes GmbH
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Kemin Industries Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Adisseo
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Chr. Hansen Holding A/S
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Lallemand Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Advanced Enzyme Technologies Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Jinan Bestzyme Bio-Engineering Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Shandong Longlive Bio-technology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Zhengzhou Tianguan Group Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Enzymes BioTech Pvt. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Jiangsu Biolight Meditech Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,930M by 2033 · 7.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Fungal Phytases71.7
- Bacterial Phytases11.6
- Plant-derived Phytases16.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$910.3M → $1,688M · 8.0%
Europe$634.4M → $1,128M · 7.5%
Asia Pacific$579.3M → $931.7M · 6.1%
Latin America$358.6M → $629.0M · 7.3%
Middle East and Africa$275.8M → $450.7M · 6.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.492026
7.502027
7.512028
7.522029
7.532030
7.542031
7.562032
7.572033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE26.7
- DuPont (IFF)11.5
- Novozymes A/S5.1
- DSM Nutritional Products14.6
- AB Enzymes GmbH8.9
- Kemin Industries Inc.5.3
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Source Type22.7%
Form21.5%
Animal Type21.7%
Application20.1%
Production Method13.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.0
- Europe23.4
- Asia Pacific19.3
- Latin America13.0
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 74 | 94 | 81 | 75 | 91 | 87 | 84 |
| DuPont (IFF) | 87 | 75 | 75 | 69 | 69 | 76 | 75 |
| Novozymes A/S | 66 | 68 | 87 | 80 | 71 | 70 | 74 |
| DSM Nutritional Products | 72 | 64 | 73 | 65 | 57 | 81 | 69 |
| AB Enzymes GmbH | 73 | 54 | 74 | 57 | 76 | 65 | 67 |
| Kemin Industries Inc. | 68 | 61 | 61 | 58 | 62 | 55 | 61 |
| Adisseo | 57 | 51 | 53 | 66 | 53 | 65 | 58 |
| Chr. Hansen Holding A/S | 54 | 36 | 54 | 55 | 45 | 55 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- DuPont (IFF)
- Novozymes A/S
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | − | ◐ | ✓ | ◐ | ◐ | ✓ |
| DuPont (IFF) | ◐ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Novozymes A/S | − | ✓ | ◐ | ◐ | ✓ | ✓ |
| DSM Nutritional Products | ◐ | ◐ | ✓ | − | ◐ | ◐ |
| AB Enzymes GmbH | ◐ | − | ✓ | − | ◐ | ✓ |
| Kemin Industries Inc. | ◐ | ◐ | ◐ | ◐ | ◐ | − |
| Adisseo | − | ◐ | ◐ | ◐ | − | ◐ |
| Chr. Hansen Holding A/S | − | − | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE84
2DuPont (IFF)75
3Novozymes A/S74
4DSM Nutritional Products69
5AB Enzymes GmbH67
6Kemin Industries Inc.61
7Adisseo58
8Chr. Hansen Holding A/S50
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
BASF SE
Challenger4
Strong scale, closing on the leaders.
DuPont (IFF)Novozymes A/SDSM Nutritional ProductsAB Enzymes GmbH
Contender2
Focused players with pockets of strength.
Kemin Industries Inc.Adisseo
Niche1
Specialists in a single segment or region.
Chr. Hansen Holding A/S
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Source Type in North America, then scale across Animal Feed Phytases Market — a $485M beachhead inside a $9.01B market.
Beachhead (SOM)$485Mobtainable near-term
Serviceable (SAM)$3.36Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Fungal Phytases
Best fit — highest urgency & budget in Source Type.
Economic buyer79 fit
Bacterial Phytases
Strong fit — clear ROI and a fast path to value.
End user64 fit
Plant-derived Phytases
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Source Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Animal Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel26%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Source Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Animal Feed Phytases Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified25%
Evaluation15%
Closed-won6%
$17.6KCAC
$65KLTV
3.7:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Animal Feed Phytases Market is a high-growth opportunity — $11.4B by 2033, compounding at 10.6%.
TAM · 2025$5.10Btoday
TAM · 2033$11.4Bforecast
CAGR10.6%2027–2033
Cumulative$71.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$11.4BTotal addressable market
SAM$4.00BServiceable available market
SOM$662MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.6% CAGR
Demand compounds through 2033, outpacing GDP across Source Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Source Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$11.4BLarge & growingTAM by 2033 at 10.6% CAGR
$4.00BServiceable nowreachable with today’s model
$662MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.90BBear6.9% CAGR
$11.4BBase10.6% CAGR
$14.6BBull14.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Animal Feed Phytases Market — a $2.77B market by 2033. Plan: grow share from 7.3% to 11.4%.
Market size · 2033$2.77Btotal addressable
Market CAGR11.3%2027–2033
Target share11.4%from 7.3% today
Revenue ambition$316Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.3% | 11.4% | Behind |
| Revenue | $215M | $316M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 31.9% | 45.9% | Ahead |
| Customer retention | 88.7% | 95.0% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Source Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Source Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $36M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Source Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskAhead
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Animal Feed Phytases Market conversation — a $8.69B market you can size, segment and defend in minutes.
Market size · 2033$8.69Btotal opportunity
Growth11.1%CAGR to 2033
Addressable buyers1,529+accounts in scope
Typical ROI7.6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Source Type
Goal Grow share in Source Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.6×return on cost, year one
< 2 mopayback period
$85K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
BASF SEDuPont (IFF)Novozymes A/SDSM Nutritional ProductsAB Enzymes GmbHKemin Industries Inc.AdisseoChr. Hansen Holding A/S+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Animal Feed Phytases Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Animal Feed Phytases Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Agriculture · scroll →Extract-Based Biostimulant Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportAquiculture Feed Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportRegular Saw Logs Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportEucalyptus Pulp Logs Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportEucaliptus Pulp Logs Debarkeds Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportSoil Steam Sterilizer Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportSelf-Propelled Forage Harvester Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportSeed Processing Equipments Market
Market size, share, segmentation and regional forecast.
$840M market · 2025 base year
View reportForestry Equipments Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportIndustry Grade Corn Starch Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportCombine Harvester Blades Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportGarlic Grinder Machine Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.